Ponsegromab
Ponsegromab (PF 06946860) is a selective and effective humanized anti-GDF15 antibody inhibitor with anti-cachexic activity. It binds to GDF15, preventing its interaction with GFRAL and disrupting GDF15/GFRAL mediated signaling. Ponsegromab has potential anticancer activity and can be used to treat cancer patients with cancer anorexia cachexia syndrome.
Product Specifications
CAS Number
2368950-15-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
TGF-beta/Smad
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6452503 1.0 µg DNA
Heatr5b sgRNA CRISPR Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
